New Zealand markets closed

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
29.14+0.39 (+1.36%)
At close: 04:00PM EDT
28.75 -0.39 (-1.34%)
After hours: 07:43PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
40,234
67,741
180,550
169,075
133,892
-
Depreciation & amortisation
122,935
123,512
118,299
119,836
116,031
-
Deferred income taxes
-16,694
-11,885
-4,585
-2,755
-64,138
-
Stock-based compensation
22,122
20,143
27,725
36,210
19,590
-
Change in working capital
-62,313
-81,574
-39,420
18,163
-41,314
-
Accounts receivable
11,379
4,593
-33,905
7,265
52,105
-
Inventory
-53,371
-59,773
-29,124
5,374
-48,348
-
Accounts payable
-34,455
-20,229
17,343
32,874
-57,512
-
Other working capital
60,929
73,090
217,384
264,347
139,942
-
Other non-cash items
15,395
21,241
-10,643
8,702
31,916
-
Net cash provided by operating activities
129,555
139,955
264,469
312,427
203,832
-
Cash flows from investing activities
Investments in property, plant and equipment
-68,626
-66,865
-47,085
-48,080
-63,890
-
Acquisitions, net
-
0
-51,509
-303,910
0
-
Purchases of investments
-71,194
-32,694
0
0
-7,840
-
Sales/maturities of investments
1,584
5,381
4,909
76
-
1,584
Other investing activities
-64,243
-
-
-
-
752
Net cash used for investing activities
-134,439
-94,178
-58,580
-161,443
-68,073
-
Cash flows from financing activities
Debt repayment
-113,300
-110,600
-148,550
-125,500
-441,000
-
Common stock issued
-
-
-
-
0
0
Common stock repurchased
-125,000
-275,000
-125,000
0
-100,000
-
Other financing activities
-4,055
-13,742
-24,618
-5,050
-29,422
-
Net cash used provided by (used for) financing activities
291,434
-229,925
-251,953
-98,226
121,625
-
Net change in cash
284,539
-180,259
-56,787
43,282
271,255
-
Cash at beginning of period
307,367
456,661
513,448
470,166
198,911
-
Cash at end of period
593,917
276,402
456,661
513,448
470,166
-
Free cash flow
Operating cash flow
129,555
139,955
264,469
312,427
203,832
-
Capital expenditure
-68,626
-66,865
-47,085
-48,080
-63,890
-
Free cash flow
60,929
73,090
217,384
264,347
139,942
-